FIELD: chemistry.
SUBSTANCE: invention relates to compound with structural formula (I) 
or to its pharmaceutically acceptable salt, where R represents cyanogroup. Invention also relates to method of obtaining said compound and to pharmaceutical composition against platelet aggregation based on the compound.
EFFECT: obtained is novel compound and based on its pharmaceutical composition, which can be applied in medicine for production of medication for prevention or treatment of diseases of cardiac and cerebral vessels, such as coronary syndromes, myocardial infarction and myocardial ischemia, caused by aggregation of platelets.
13 cl, 3 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DEUTERATED THIENOPIPERIDINE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2016 |
|
RU2716141C2 |
| HYDROPYRIDINE DERIVATIVE ACID ADDITIVE SALTS | 2001 |
|
RU2238275C1 |
| METHOD OF PRODUCING CLOPIDOGREL AND DERIVATIVES THEREOF | 2009 |
|
RU2469039C2 |
| DERIVATIVES OF TETRAHYDROTHIENO-[3,2-C]-PYRIDINE OR THEIR FURO-ANALOGS AND A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2089553C1 |
| COMPOUND HAVING THROMBOCYTE AGGREGATION INHIBITION ACTION, AND A SALT THEREOF, AND A COMPOSITION COMPRISING SUCH COMPOUNDS FOR PREVENTING OR TREATING THROMBOTIC DISEASES | 2016 |
|
RU2739915C2 |
| TETRAHYDROISOQUINOLINE COMPOUND AS A POTASSIUM CHANNELS MODULATOR, ITS PREPARATION AND APPLICATION | 2021 |
|
RU2800873C1 |
| NITROGEN-CONTAINING HETEROCYCLIC AMIDE AND ITS USE FOR MEDICAL PURPOSES | 2019 |
|
RU2789670C2 |
| METHODS OF TREATING OR PREVENTING THROMBOSIS OR EMBOLISM | 2011 |
|
RU2611662C2 |
| NEW PROSTAGLANDIN DERIVATIVE | 2017 |
|
RU2748837C2 |
| PYRIMIDOBENZIMIDAZOLE DERIVATIVES AND APPLICATION THEREOF AS AGONISTS OR ANTAGONISTS OF MELANOCORTIN RECEPTORS | 2005 |
|
RU2392279C2 |
